ArticleHeart Asia2015
The 2014 hypertension guidelines: implications for patients and practitioners in Asia.
Article in Heart Asia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Effects of hypertension in patients receiving mechanical thrombectomy: A meta-analysis.Medicine · 2020Pooled it
- Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Network.Journal of human hypertension · 2018Guideline
- Systemic Capillary Responses to Acute Exercise in Hypertensive Seniors: Insights from a Single-Center Pilot Study.Journal of clinical medicine · 2024Article
- Cognitive impairment in heart failure patients: association with abnormal circadian blood pressure rhythm: a review from the HOPE Asia Network.Hypertension research : official journal of the Japanese Society of Hypertension · 2024Review
- Transition of May Measurement Month to an online hypertension awareness campaign in Korea during the COVID-19 pandemic.European heart journal. Digital health · 2021Article
- Current status of adherence interventions in hypertension management in Asian countries: A report from the HOPE Asia Network.Journal of clinical hypertension (Greenwich, Conn.) · 2020Article
- Current status of ambulatory blood pressure monitoring in Asian countries: A report from the HOPE Asia Network.Journal of clinical hypertension (Greenwich, Conn.) · 2020Review
- Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network.Journal of clinical hypertension (Greenwich, Conn.) · 2020Review
- Age related structural and functional changes in left ventricular performance in healthy subjects: a 2D echocardiographic study.The international journal of cardiovascular imaging · 2019Article
- Hypertension and Dementia: A comprehensive review from the HOPE Asia Network.Journal of clinical hypertension (Greenwich, Conn.) · 2019Review
- Managing hypertension in 2018: which guideline to follow?Heart Asia · 2019Article
- Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension.Clinical hypertension · 2018Article
- Current status of home blood pressure monitoring in Asia: Statement from the HOPE Asia Network.Journal of clinical hypertension (Greenwich, Conn.) · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is a global public health issue and a major cause of morbidity and mortality. Because of population growth and ageing, the number of people with uncontrolled hypertension rose from 600 million in 1980 to nearly 1 billion in 2008. Furthermore, the number of adults with hypertension in 2025 has also been predicted to increase by about 60% to a total of 1.56 billion. The prevalence of hypertension in most Asian countries has increased over the last 30 years and more dramatically in the last 10 years. Several factors contributed to such changes in Asia, but acculturation to Western lifestyle, modernisation and urbanisation are considered key contributing factors. There are some unique features in regards to cardiovascular risk in Asia. Specifically, Asian regions have disproportionately higher mortality and morbidity from stroke compared with Western countries. Furthermore, the relationship between blood pressure level and risk of stroke is stronger in Asia than in Western regions. Although evidence-based and qualified guidelines for hypertension diagnosis and management have been released recently from Europe and North America, the unique features of Asian patients with hypertension raise concerns in regards to the real clinical applicability of Western guidelines in Asian populations. Specifically, it is not yet clear to what extent the new blood pressure target proposed by Western guidelines for high risk and elderly hypertensive individuals apply to Asian populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.